Ledermann JA, Shapira-Frommer R, Santin AD, Lisyanskaya AS, et al. Molecular determinants of clinical outcomes of pembrolizumab in recurrent ovarian cancer: Exploratory analysis of KEYNOTE-100. Gynecol Oncol 2023;178:119-129.
PMID: 37862791